BCIwiki — Brain-computer interface news, research and industry database

A Stanford program is recording brain activity in psychiatric inpatients at millisecond precision, combining noninvasive electrode arrays with deep brain recording electrodes to trace the circuits behind schizoaffective disorder, borderline personality disorder, autism and cancer-induced depression. The Human Neural Circuitry program, led by neuroscientist Karl Deisseroth at the Wu Tsai Neurosciences Institute, has run for three years and moves data over fiber-optic and copper links fast enough for round trips of under half a millisecond, allowing the system to sense and respond in a closed loop. Deisseroth said the key innovation is getting results at millisecond precision, which he called a crucial step toward understanding complex psychiatric symptoms.

Published in Neural Regeneration Research on August 18, 2026, the study conducted a bibliometric analysis of 3173 articles from the Web of Science Core Collection on post-stroke limb motor dysfunction and functional recovery from 2016 to 2025, by authors from Beijing Rehabilitation Hospital, Capital Medical University. The field is in a period of rapid expansion, with technology-assisted rehabilitation as the dominant trend and robot-assisted training and virtual reality as the two major technological keywords. Burst literature analysis revealed three hotspot phases, with the recent phase (2020 to present) covering neuromodulation (brain-computer interface and non-invasive brain stimulation), global disease burden and public health policy. Highly cited studies focus on comparative efficacy, robot-assisted training, brain-computer interfaces, vagus nerve stimulation and prediction of rehabilitation outcomes.

Chinese insurers have begun introducing BCI-related coverage. Shanghai's 2026 Hu-huibao plan added up to 150,000 yuan for out-of-pocket materials used in inpatient BCI surgery, PICC Property and Casualty underwrote an invasive-BCI surgical accident policy for the Second Affiliated Hospital of Zhejiang University School of Medicine, and China Pacific Property Insurance covered patients receiving Neuracle's NEO implant at Huashan Hospital.

Researchers report that a BCI-controlled sixth-finger neurofeedback intervention improved motor function in stroke: after 8 sessions (2 weeks) of motor-imagery BCI training, 14 patients gained an average of 7.9 points on FMA-UE and 7.1 on the Barthel Index, with 9 of 14 reaching the 6.6-point minimally clinically important difference. EEG tracking across the full intervention showed a two-phase ERD trend that strengthened in week one and narrowed to the contralateral sensorimotor area in week two, and resting-state functional connectivity rose afterward, correlating with motor gains. The authors say the work offers longitudinal evidence on neuroplasticity in stroke rehabilitation.

Six Fujian government departments jointly issued a provincial BCI action plan for 2026–2030. It calls for key technical breakthroughs, more than five innovative small and medium-sized companies, one cross-strait joint laboratory and two provincial innovation platforms by 2027; by 2030, Fujian aims to have 30 companies, a complete industry chain and an industry worth more than 3 billion yuan.

The Orion visual neuroprosthetic system, originally developed by Second Sight Medical Products, is changing parent companies again, Neurotech Reports said. Vivani Medical has agreed a reverse merger with Nasdaq-listed ClearOne under which its Cortigent unit becomes a wholly owned ClearOne subsidiary; ClearOne will be renamed Cortigent Holdings Inc. and is expected to trade as CRGT. ClearOne agreed as part of the transaction to file a Form S-1 registration statement to raise $10 million to $15 million, and Cortigent plans a pivotal trial of Orion in about 60 patients, though funding remains a challenge.

A new clinical trial at Brazil's Santos Dumont Institute will test whether brain-computer interface (BCI)-guided functional electrical stimulation (FES) can improve muscle activation and gait in people with spinal cord injury. The institute is a well-known Brazilian center for neurorehabilitation research. Registered on ClinicalTrials.gov as NCT07768930 and first posted on August 17, 2026, the study is active but not yet recruiting. The intervention involves ankle dorsiflexion rehabilitation: patients wear an EEG cap, the system detects motor-imagery-related brain signals in real time, and when an intention is detected, it triggers FES to stimulate the tibialis anterior muscle to assist ankle dorsiflexion. Primary outcomes are improvements in muscle activation patterns and gait kinematics. The trial is at an early stage, with enrollment details not yet disclosed.

A systematic review of BCI medical applications published on August 17, 2026 in Theoretical and Natural Science covers literature review, comparative case analysis of invasive vs non-invasive techniques, and interdisciplinary assessment. It reports that invasive BCIs reach 80% to 100% task success rates in robotic arm control but are limited by surgical hazards, progressive signal deterioration and costs above $250,000, while non-invasive BCIs are safer and more widely deployed in community neurorehabilitation with about 70% effectiveness for post-stroke upper-limb recovery, yet suffer poor signal-to-noise ratios, a BCI illiteracy rate near 30% and low information transfer speeds. The review also addresses neural data privacy, autonomy paradoxes and inequitable access.